S-Ketamine vs. R-Ketamine
In early 2019, an esketamine nasal spray was approved by the FDA for adults with treatment-resistant depression. Its FDA-approved uses were later expanded to include patients suffering from acute suicidal ideation. But what is esketamine, and how is it different from regular ketamine?